PAVM PAVMED INC Capital Structure Changes 8-K Filing 2024 - Debt Exchange Agreement Pavmed Inc. has entered into a Debt Exchange Agreement to convert $22.35 million of convertible notes into 22,347 shares of Series C Preferred Stock, and also plans to purchase 2,653 shares of Series C Preferred Stock for $2.65 million through debt cancellation, pending stockholder approval by January 31, 2025.Get access to all SEC 8-K filings of the PAVMED INC